European Archives - Page 6 of 1216 - European Medical Journal

Long COVID: Cardiovascular Patterns Revealed with Smartwatch Biometrics

Wearables reveal unique activity and heart rate patterns in long COVID, showing promise as clinical biomarkers.

Pyridostigmine Boosts Recovery in Underactive Bladder Post-TURP

Taken together, the findings suggest that targeted augmentation of cholinergic signalling may help bridge the gap between anatomical de-obstruction and functional recovery in BOO-mediated UAB.

Renal Dysfunction Persists Despite Pulmonary Hypertension Treatment

A large pooled analysis shows that kidney problems are common in PAH and CTEPH, worsen survival, and see only minor improvement with current pulmonary hypertension therapies.

Headshots of Julia Strandberg, Yacin Marzouki and Catarina Sobral.

Pharma marketing: What’s working for HCPs in 2025

Pharma marketing experts reveal what’s working to engage time-pressed HCPs in 2025, with practical insights and metrics for improving impact.

Brain Scan Links Dopamine Changes To Psychosis Across Mood Disorders

Dopamine changes link to psychotic symptoms, suggesting new treatment avenues for mood disorders with psychosis.

Novel Bispecific Antibody Shows Promise Against Aggressive Blood Cancers

A new bispecific antibody therapy, AFM28, has shown strong preclinical results in targeting treatment-resistant cells in acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS), according to new research.

Intermittent Fasting Might Improve Symptoms of Long COVID-19

Intermittent fasting decreased symptoms of long COVID-19 in a randomised crossover trial that compared the efficacy and safety of 4 weeks of 1–2-day fasting plus a restricted diet versus 4 weeks of mild time-restricted eating and a restricted diet

Get to Know Tau and its role in Alzheimer's Disease

Suzanne Schindler provides her perspectives from Clinical Trials on Alzheimer’s Disease (CTAD) 2024 on plasma tau biomarkers, covering…

Current Trends of Methotrexate Therapy

Methotrexate (MTX) in rheumatoid arthritis (RA) care in this expert-led symposium led by expert rheumatologists. Benefits of subcutaneous MTX, vaccination considerations during MTX therapy and lessons from COVID-19, updates on second-line combination treatments, and the latest evidence on MTX-associated fibrotic interstitial lung disease.

Illustration of scientific tools

Novartis to tackle rare disease diagnosis with AI

Novartis is partnering with Atropos Health to develop AI models that accelerate rare disease diagnosis, starting with a rare blood disorder.